THE LNCRNA SIGNATURE ASSOCIATED WITH CUPROPTOSIS AS A NOVEL BIOMARKER OF PROGNOSIS IN IMMUNOTHERAPY AND DRUG SCREENING FOR CLEAR CELL RENAL CELL CARCINOMA

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma

Cuproptosis is a new form of cell death, the second form of metal ion-induced cell death defined after ferroptosis.Recently, cuproptosis has been suggested to be associated with tumorigenesis.However, the relationship between cuproptosis and patient prognosis in clear cell renal cell carcinoma (ccRCC) in the context of immunotherapy remains unknown

read more


Chloramphenicol Resurrected: A Journey from Antibiotic Resistance in Eye Infections to Biofilm and Ocular Microbiota

The advent of multidrug resistance among pathogenic bacteria is devastating the worth of antibiotics and changing the way of their administration, as well as the approach to use new or old drugs.The crisis of antimicrobial resistance is also due to the unavailability of newer drugs, attributable to exigent regulatory requirements and reduced financ

read more